AFJK (Aimei Health Technology Co., Ltd Ordinary Share) Stock Analysis - AI Report
Aimei Health Technology Co., Ltd Ordinary Share (AFJK) is a publicly traded Financial Services sector company. As of May 21, 2026, AFJK trades at $40.77 with a market cap of $131.72M and a P/E ratio of 0.00. AFJK moved +13.03% today. Year to date, AFJK is -4.17%; over the trailing twelve months it is +296.33%. Its 52-week range spans $6.75 to $130.37. Rallies surfaces AFJK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on AFJK?
Rallies AI research for AFJK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
MIZUHO SECURITIES USA LLC sold 150.00K (~$1.63M) on Feb 11, 2025.
Aimei Investment Ltd bought 332.00K (~$3.32M) on Dec 1, 2023.
AFJK Analyst Consensus
AFJK analyst coverage data. Average price target: $0.00.
Common questions about AFJK
What is the AI research view on AFJK?
Rallies AI research for AFJK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for AFJK?
Rallies AI research for AFJK combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is AFJK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AFJK. It does not provide personalized investment advice.
